NEW YORK, Dec. 19, 2017 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential sale of Kindred Healthcare Inc. (NYSE: KND) ("Kindred" or the "Company") on behalf of its shareholders. Kindred announced that it has entered into a definitive agreement to be acquired by a consortium of three companies: TPG Capital; Welsh, Carson, Anderson & Stowe; and Humana Inc. in a cash deal valued at approximately $4.1 billion. The Consortium will acquire Kindred for $9 in cash per share.
Our investigation has determined that the offer price of only $9 per share, unfairly under-values the true going forward inherent value of Kindred and that shareholders may not be receiving the maximum value for their shares. Indeed, the stock reached a high of $11.90 per share this year. The investigation further seeks to determine whether Kindred's senior management is entering into this deal for their own self-interests to the detriment of the Company's shareholders.
If you are a shareholder of Kindred and would like additional information as to how the proposed acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares at no cost, please contact us at:
Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and has assisted in the recovery of billions of dollars for shareholders in securities actions around the globe.
Attorney advertising. Prior results do not indicate a similar outcome.
SOURCE Tripp Levy PLLC